493 related articles for article (PubMed ID: 25867633)
1. Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model.
Garrido P; Ribeiro S; Fernandes J; Vala H; Bronze-da-Rocha E; Rocha-Pereira P; Belo L; Costa E; Santos-Silva A; Reis F
PLoS One; 2015; 10(4):e0124048. PubMed ID: 25867633
[TBL] [Abstract][Full Text] [Related]
2. Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.
Garrido P; Ribeiro S; Fernandes J; Vala H; Rocha-Pereira P; Bronze-da-Rocha E; Belo L; Costa E; Santos-Silva A; Reis F
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712750
[TBL] [Abstract][Full Text] [Related]
3. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
Landau D; London L; Bandach I; Segev Y
PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
[TBL] [Abstract][Full Text] [Related]
4. Pathological and molecular mechanisms underlying resistance to recombinant human erythropoietin therapy in the remnant kidney rat model of chronic kidney disease associated anemia.
Ribeiro S; Garrido P; Fernandes J; Vala H; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
Biochimie; 2016 Jun; 125():150-62. PubMed ID: 27039028
[TBL] [Abstract][Full Text] [Related]
5. Liver iron is a major regulator of hepcidin gene expression via BMP/SMAD pathway in a rat model of chronic renal failure under treatment with high rHuEPO doses.
Ribeiro S; Garrido P; Fernandes J; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
Biofactors; 2016 May; 42(3):296-306. PubMed ID: 26990350
[TBL] [Abstract][Full Text] [Related]
6. Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose.
Ribeiro S; Garrido P; Fernandes J; Vala H; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):343-54. PubMed ID: 26889660
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin in chronic kidney disease anemia.
Santos-Silva A; Ribeiro S; Reis F; Belo L
Vitam Horm; 2019; 110():243-264. PubMed ID: 30798815
[TBL] [Abstract][Full Text] [Related]
8. A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
Olivari V; Di Modica SM; Lidonnici MR; Aghajan M; Cordero-Sanchez C; Tanzi E; Pettinato M; Pagani A; Tiboni F; Silvestri L; Guo S; Ferrari G; Nai A
Kidney Int; 2023 Jul; 104(1):61-73. PubMed ID: 36990212
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
Orlic L; Mikolasevic I; Lukenda V; Racki S; Stimac D; Milic S
Med Hypotheses; 2014 Dec; 83(6):798-801. PubMed ID: 25456789
[TBL] [Abstract][Full Text] [Related]
10. Characterization of erythropoietin and hepcidin in the regulation of persistent injury-associated anemia.
Alamo IG; Kannan KB; Smith MA; Efron PA; Mohr AM
J Trauma Acute Care Surg; 2016 Oct; 81(4):705-12. PubMed ID: 27398985
[TBL] [Abstract][Full Text] [Related]
11. A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.
Sun CC; Vaja V; Chen S; Theurl I; Stepanek A; Brown DE; Cappellini MD; Weiss G; Hong CC; Lin HY; Babitt JL
Nephrol Dial Transplant; 2013 Jul; 28(7):1733-43. PubMed ID: 23345622
[TBL] [Abstract][Full Text] [Related]
12. Down-Regulation of Cardiac Erythropoietin Receptor and its Downstream Activated Signal Transducer Phospho-STAT-5 in a Rat Model of Chronic Kidney Disease.
Hertzberg-Bigelman E; Barashi R; Levy R; Cohen L; Ben-Shoshan J; Keren G; Entin-Meer M
Isr Med Assoc J; 2016 Jun; 18(6):326-30. PubMed ID: 27468524
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.
Wagner M; Ashby DR; Kurtz C; Alam A; Busbridge M; Raff U; Zimmermann J; Heuschmann PU; Wanner C; Schramm L
PLoS One; 2015; 10(4):e0123072. PubMed ID: 25894587
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid modulates iron metabolism imbalance in anemia of inflammation induced by LPS via reversely regulating hepcidin and ferroportin expression.
Han L; Liu Y; Lu M; Wang H; Tang F
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):280-285. PubMed ID: 30446224
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of the sensory and regulatory pathways controlling cellular iron metabolism in unilateral obstructive nephropathy.
Votava JA; Reese SR; Deck KM; Nizzi CP; Anderson SA; Djamali A; Eisenstein RS
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F89-F103. PubMed ID: 34843656
[TBL] [Abstract][Full Text] [Related]
17. Whole-body iron transport and metabolism: Mechanistic, multi-scale model to improve treatment of anemia in chronic kidney disease.
Sarkar J; Potdar AA; Saidel GM
PLoS Comput Biol; 2018 Apr; 14(4):e1006060. PubMed ID: 29659573
[TBL] [Abstract][Full Text] [Related]
18. Iron as the key modulator of hepcidin expression in erythroid antibody-mediated hypoplasia.
Fernandes JC; Garrido P; Ribeiro S; Rocha-Pereira P; Bronze-da-Rocha E; Belo L; Costa E; Reis F; Santos-Silva A
Biomed Res Int; 2014; 2014():421304. PubMed ID: 25580431
[TBL] [Abstract][Full Text] [Related]
19. Possible mechanisms by which silkworm faeces extract ameliorates adenine-induced renal anaemia in rats.
Mei H; Wu N; Huang X; Cui Z; Xu J; Yang X; Zeng F; Wang K
J Ethnopharmacol; 2021 Feb; 266():113448. PubMed ID: 33022342
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
Jain M; Joharapurkar A; Patel V; Kshirsagar S; Sutariya B; Patel M; Patel H; Patel PR
Eur J Pharmacol; 2019 Jan; 843():113-120. PubMed ID: 30458168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
